45.06 +0.71 (1.58%)
GSK
| Trade GSK now with |
Stock Details
Last Trade:45.06 Change:+0.71 (1.58%) Prev Close:44.35 Open: 44.90 Days Range:44.71 – 45.14 52 Week Range: 36.39 - 46.50 Volume:3005912 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/12
Recent Alert on 02/07/12 at 9:32am
Pre-Open Movers 2/7: (CSTR) (FN) (NCR) Higher; (KNXA) (CFX) (RATE) Lower (more...)
Pre-Open Movers 2/7: (CSTR) (FN) (NCR) Higher; (KNXA) (CFX) (RATE) Lower (more...)
Below are stocks making major moves in pre-open trading Tuesday HIGHER: Coinstar, Inc. (NASDAQ: CSTR) 19% HIGHER; tops Q4 views, buys NCR's (NYSE: NCR) DVD business. Fabrinet (NYSE: FN) 14% HIGHER; upgraded Standard Pacific Corp. (NYSE: SPF)... Read More
Recent Alert on 02/06/12 at 8:31am
Glaxo (GSK) Halts Enrollment in GSK '052 Phase 2b Following Recent Discovery (ANAC)
Glaxo (GSK) Halts Enrollment in GSK '052 Phase 2b Following Recent Discovery (ANAC)
Recent Alert on 02/06/12 at 8:31am
Glaxo (GSK) Halts Enrollment in GSK '052 Phase 2b Following Recent Discovery (ANAC)
Glaxo (GSK) Halts Enrollment in GSK '052 Phase 2b Following Recent Discovery (ANAC)
View AllRecent Press Releases
Press Release on 02/07/12 at 11:33am
Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen
Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen
Press Release on 02/07/12 at 11:33am
Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen
Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen
Press Release on 02/06/12 at 9:00am
A Forward Look, the Year Ahead - Featured Research on Amarin Corporation plc (ADR) and GlaxoSmithKline plc (ADR)
A Forward Look, the Year Ahead - Featured Research on Amarin Corporation plc (ADR) and GlaxoSmithKline plc (ADR)
Press Release on 02/06/12 at 9:00am
A Forward Look, the Year Ahead - Featured Research on Amarin Corporation plc (ADR) and GlaxoSmithKline plc (ADR)
A Forward Look, the Year Ahead - Featured Research on Amarin Corporation plc (ADR) and GlaxoSmithKline plc (ADR)


